COMORBIDITIES IN PSORIATIC ARTHRITIS AND PSORIASIS: CONSIDERATIONS FOR THE CLINICIAN

Abstract

Objectives: to assess the practical clinical value of comorbidities in psoriasis and psoriatic arthritis. Material and methods. A group of 92 patients, with psoriatic arthritis, established in accordance with the CASPAR diagnostic criteria (2006) was selected with a prospective study with retrospective components. The average age of patients with psoriatic arthritis was 42.9±9.6 years, the average duration of psoriasis was 11 (7; 25.8) years, the average duration of psoriatic arthritis was 7 (2; 11.8) years. Among the patients included in the study were 42 (45.7%) men and 50 (54.3%) women. Results. The most common pathology was hypertension with a frequency of 38%, exertional angina – in 5.4% and postinfarct cardiosclerosis – in 2.2%, chronic heart failure – in 6.5% of patients. Cardiovascular pathology combined with diabetes mellitus, dyslipidemia, etc., was observed in 16.3% of patients. Cerebrovascular disorders were detected in 3.3%. Conclusions. A holistic approach to patients with PsA and Ps is recommended – focusing not only on skin or joint symptoms, but also on all aspects of the disease, including comorbidities, can improve the management of the disease and prevent long-term mental and physical impairment.

Keywords

• psoriatic arthritis
• psoriasis
• comorbidities
• clinician's guidelines